According to filings with the U.S. Securities and Exchange Commission, Synthpop is raising up to $14,999,992.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

About Synthpop
Backed by decades of experience in healthcare, the Synthpop team offers scalable, reliable solutions and services that address the specific needs of healthcare manufacturers, suppliers, and software solutions. Synthpop reduces administrative burden by automating complex intake and data entry processes, and placing calls to payors. Our team of AI experts integrate custom solutions with existing enterprise systems, enabling smooth operations without the need for complicated configurations. .

To learn more about Synthpop, visit https://www.synthpop.ai/
Synthpop Linkedin Page: https://www.linkedin.com/company/synthpop/

Contact:
Elad Ferber, Chief Executive Officer
650-690-4577
https://www.linkedin.com/in/eladferber/

SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.